MedTrace Logo

Therapeutic Individualization for Patients With Locally Advanced Gastric and Gastroesophageal Cancer

NCT02454673 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2015-05-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether the R0 rate, pathological response degree, patterns of recurrence and long-term outcomes may be initially predicted in patients with locally advanced gastroesophageal junction and gastric cancer treated with a neoadjuvant approach and salvage surgery.

Conditions

Sponsors & Collaborators

  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Principal Investigators

  • Javier Rodriguez Rodriguez, MD, PhD · Clinica Universidad de Navarra

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02454673 on ClinicalTrials.gov